Sectors

The drug retailer’s AB Health Ventures unit will focus on early to mid-stage healthcare technology providers working on areas including pharmaceutical distribution, commercialisation and pet care.

Q&A with Meryem Aydin, senior investment analyst, Amadeus Ventures

The Stripe-backed rapid checkout tool developer was valued at $1bn early last year but is closing its doors after failing to raise more cash.

The gut microbiome drug developer went public in a $22.5m offering priced at the foot of its range.

The electronics subscription service received $110m in equity and $220m in debt financing from a consortium including Assurant, SevenVentures and Mirae Asset-LG Electronics New Growth Fund.

SoftBank Vision Fund 2 led the healthcare management software provider’s series D round, taking its overall funding to about $213m and its valuation to a reported $1.4bn.

The company, which largely remains in stealth mode, has set itself a mission of increasing the human lifespan by a decade.

Prologis Ventures has returned to back the Associated Press, Samsung Next and Workday Ventures-backed business data software developer’s latest round, hiking its funding to over $132m in total.

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

Kaiser Permanente Ventures returned to reinvest in the nursing staff management service at a $1.1bn valuation.

Crypto.com, Huobi and BitMart invested in cryptocurrency scaling technology developer Boba Network at a $1.5bn valuation while natural fibre composite provider Bcomp netted $34.9m in a BMW-led round.